Bilimsel Makale Arama | NeuralCipher AI

Kaynak kaydı

Motor phenotype of LRRK2-associated Parkinson's disease: a Tunisian longitudinal study.

Nabli F, Ben Sassi S, Amouri R, Duda JE, Farrer MJ, Hentati F.

Mov Disord · 2014-12-09

DOI: 10.1002/mds.26097PMID: 25487881

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

An association analysis of the R1628P and G2385R polymorphisms of the LRRK2 gene in multiple system atrophy in a Chinese population.

Yuan X, Chen Y, Cao B, Zhao B, Wei Q, Guo X, Yang Y, Yuan L, Shang H.

Parkinsonism Relat Disord · 2014-12-03

DOI: 10.1016/j.parkreldis.2014.11.022PMID: 25511328

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Neuropsychological performance in LRRK2 G2019S carriers with Parkinson's disease.

Alcalay RN, Mejia-Santana H, Mirelman A, Saunders-Pullman R, Raymond D, Palmese C, Caccappolo E, Ozelius L, Orr-Urtreger A, Clark L, Giladi N, Bressman S, Marder K, LRRK2 Ashkenazi Jewish Consortium.

Parkinsonism Relat Disord · 2014-11-20

DOI: 10.1016/j.parkreldis.2014.09.033PMID: 25434972

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

The Upshot of LRRK2 Inhibition to Parkinson's Disease Paradigm.

Esteves AR, G-Fernandes M, Santos D, Januário C, Cardoso SM.

Mol Neurobiol · 2014-11-15

DOI: 10.1007/s12035-014-8980-6PMID: 25394383

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

The role of the LRRK2 gene in Parkinsonism.

Li JQ, Tan L, Yu JT.

Mol Neurodegener · 2014-11-12

DOI: 10.1186/1750-1326-9-47PMID: 25391693

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Identification of candidate genes for Parkinson's disease through blood transcriptome analysis in LRRK2-G2019S carriers, idiopathic cases, and controls.

Infante J, Prieto C, Sierra M, Sánchez-Juan P, González-Aramburu I, Sánchez-Quintana C, Berciano J, Combarros O, Sainz J.

Neurobiol Aging · 2014-11-05

DOI: 10.1016/j.neurobiolaging.2014.10.039PMID: 25475535

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

The role of SNCA and MAPT in Parkinson disease and LRRK2 parkinsonism in the Tunisian Arab-Berber population.

Trinh J, Gustavsson EK, Guella I, Vilariño-Güell C, Evans D, Encarnacion M, Sherman H, Hentati F, Farrer MJ.

Eur J Neurol · 2014-11-01

DOI: 10.1111/ene.12489PMID: 25303626

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

LRRK2 pathobiology in Parkinson's disease.

Martin I, Kim JW, Dawson VL, Dawson TM.

J Neurochem · 2014-10-10

DOI: 10.1111/jnc.12949PMID: 25251388

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

The complex relationships between microglia, alpha-synuclein, and LRRK2 in Parkinson's disease.

Schapansky J, Nardozzi JD, LaVoie MJ.

Neuroscience · 2014-10-02

DOI: 10.1016/j.neuroscience.2014.09.049PMID: 25284317

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

A novel mitochondrially-targeted apocynin derivative prevents hyposmia and loss of motor function in the leucine-rich repeat kinase 2 (LRRK2(R1441G)) transgenic mouse model of Parkinson's disease.

Dranka BP, Gifford A, McAllister D, Zielonka J, Joseph J, O'Hara CL, Stucky CL, Kanthasamy AG, Kalyanaraman B.

Neurosci Lett · 2014-09-26

DOI: 10.1016/j.neulet.2014.09.042PMID: 25263790

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Conditional expression of Parkinson's disease-related R1441C LRRK2 in midbrain dopaminergic neurons of mice causes nuclear abnormalities without neurodegeneration.

Tsika E, Kannan M, Foo CS, Dikeman D, Glauser L, Gellhaar S, Galter D, Knott GW, Dawson TM, Dawson VL, Moore DJ.

Neurobiol Dis · 2014-08-29

DOI: 10.1016/j.nbd.2014.08.027PMID: 25174890

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Cognitive dysfunction in Parkinson's disease related to the R1441G mutation in LRRK2.

Estanga A, Rodriguez-Oroz MC, Ruiz-Martinez J, Barandiaran M, Gorostidi A, Bergareche A, Mondragon E, Lopez de Munain A, Marti-Masso JF.

Parkinsonism Relat Disord · 2014-07-30

DOI: 10.1016/j.parkreldis.2014.07.005PMID: 25127457

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kayıtlar bilimsel kaynaklardan alınır. Bibliyografik kayıt sayısı, Türkçe çeviri veya editoryal onay sayısı değildir.

785 makale bulundu

Motor phenotype of LRRK2-associated Parkinson's disease: a Tunisian longitudinal study.

An association analysis of the R1628P and G2385R polymorphisms of the LRRK2 gene in multiple system atrophy in a Chinese population.

Neuropsychological performance in LRRK2 G2019S carriers with Parkinson's disease.

The Upshot of LRRK2 Inhibition to Parkinson's Disease Paradigm.

The role of the LRRK2 gene in Parkinsonism.

Identification of candidate genes for Parkinson's disease through blood transcriptome analysis in LRRK2-G2019S carriers, idiopathic cases, and controls.

The role of SNCA and MAPT in Parkinson disease and LRRK2 parkinsonism in the Tunisian Arab-Berber population.

LRRK2 pathobiology in Parkinson's disease.

The complex relationships between microglia, alpha-synuclein, and LRRK2 in Parkinson's disease.

A novel mitochondrially-targeted apocynin derivative prevents hyposmia and loss of motor function in the leucine-rich repeat kinase 2 (LRRK2(R1441G)) transgenic mouse model of Parkinson's disease.

Conditional expression of Parkinson's disease-related R1441C LRRK2 in midbrain dopaminergic neurons of mice causes nuclear abnormalities without neurodegeneration.

Cognitive dysfunction in Parkinson's disease related to the R1441G mutation in LRRK2.

Filtreler